Saikosaponin-d suppresses cell growth in renal cell carcinoma through EGFR/p38 signaling pathway

Related Experiment Video

Updated: Mar 2, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K

C Cai, H Zhang, Y Ou

    Neoplasma
    |May 10, 2017
    PubMed

    Insights

    Saikosaponin-d (SSd) effectively inhibits renal cell carcinoma (RCC) growth by inducing apoptosis and cell cycle arrest. This compound shows promise for RCC treatment by targeting key cellular pathways.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Pharmacology

    Background:

    • Renal cell carcinoma (RCC) is a significant global health concern.
    • Identifying novel therapeutic agents for RCC remains a critical research area.

    Purpose of the Study:

    • To investigate the anti-cancer effects of Saikosaponin-d (SSd) on renal cell carcinoma (RCC).
    • To elucidate the underlying molecular mechanisms of SSd-induced anti-cancer activity, including apoptosis and cell cycle regulation.

    Main Methods:

    • MTT assay and colony formation assay were used to assess cell proliferation.
    • Flow cytometry was employed to analyze apoptosis and cell cycle distribution.
    • Western blotting or similar techniques were used to investigate signaling pathway activation (e.g., EGFR/p38) and p53 expression.

    Main Results:

    • Saikosaponin-d (SSd) significantly inhibited proliferation in RCC cell lines (769-P and 786-O).
    • SSd treatment induced apoptosis and G0/G1 cell cycle arrest in RCC cells.
    • The mechanism involves up-regulation of p53 and inhibition of EGFR/p38 signaling pathways.

    Conclusions:

    • Saikosaponin-d (SSd) demonstrates potent anti-cancer properties against renal cell carcinoma (RCC) in vitro.
    • SSd's therapeutic potential lies in its ability to induce apoptosis, arrest cell cycle, and modulate key signaling pathways.
    • SSd represents a promising candidate for future chemopreventive or chemotherapeutic strategies in RCC treatment.
    Keywords:
    RCCSaikosaponin-dcell growth EGFR/p38.

    More Related Videos

    Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

    Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

    Published on: August 23, 2024

    1000
    Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease08:15

    Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

    Published on: May 10, 2024

    1.0K

    Related Concept Videos

    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    4.9K
    PI3K/mTOR/AKT Signaling Pathway01:22

    PI3K/mTOR/AKT Signaling Pathway

    The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
    5.9K
    Inhibition of Cdk Activity02:34

    Inhibition of Cdk Activity

    The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
    6.1K
    Mitogens and the Cell Cycle02:38

    Mitogens and the Cell Cycle

    Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
    8.2K
    Interactions Between Signaling Pathways01:19

    Interactions Between Signaling Pathways

    Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
    Convergence and divergence, and cross-talk between signaling pathways
    Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
    7.5K
    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
    5.3K